Latest news with #AmesiteInc
Yahoo
25-06-2025
- Business
- Yahoo
Amesite's HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) — accounting for 19.2% of the nursing workforce — and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL) International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Madison Bush, Director of Corporate Operations, said, 'This rollout reflects our disciplined approach to targeting segments with clear, documented needs — including the nearly one in five nurses in the U.S. who speak English as a second language. By addressing the needs of this workforce, who must document in English, we're positioned to capture value domestically and expand internationally.' Sai Nittala, Senior AI Manager, said, 'NurseMagic™ V3.0 delivers healthcare charting solutions that outperform generic, off-the-shelf AI tools. Unlike many unregulated or non-integrated solutions, NurseMagic™ is designed for seamless integration into critical healthcare workflows — where compliance, accuracy, and efficiency are essential. Our multilingual capability underscores our ability to scale rapidly while meeting real-world needs.'' Dr. Ann Marie Sastry, Founder & CEO, said, 'We have growing B2B traction following our launch of enterprise administration tools, and are also supporting B2C growth in new segments that prepare us for global expansion. As reported in our Q3 2025 10‑Q, we achieved a 2.4× quarter-on-quarter revenue increase while continuing to cut operating expenses. We believe we're on track for further revenue growth and cost efficiencies in coming quarters.' NurseMagic™ is Now Available In: English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, Swedish. Amesite recently announced a 2.4x quarter-over-quarter revenue increase in its 10-Q filing, driven by rapid adoption of its NurseMagic™ platform and improvements in operating efficiency. The company also launched a higher-priced enterprise tier in response to growing B2B demand for more capacity. In April, Amesite reported that NurseMagic™ meets HIPAA requirements for individual users and enterprises, enabling secure documentation of protected health information across all user types. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ Sources in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Yahoo
25-06-2025
- Business
- Yahoo
Amesite's HIPAA Compliant NurseMagic™ App Now Operates in 16 Languages — Expanding Access to AI-Powered Charting for Nearly 1 Million U.S. Nurses
NurseMagic™ V3.0 uniquely addresses the needs of approximately 20% of U.S. nurses in the U.S. with AI-powered charting in their native language DETROIT, June 25, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced that its flagship app, NurseMagic™, now supports charting in 16 languages. This major enhancement is designed to address a key barrier to success for nearly 1 million nurses in the U.S. who speak English as a second language (ESL) — accounting for 19.2% of the nursing workforce — and to chart more efficiently and with greater confidence. This multilingual capability positions Amesite to meet immediate market needs. Markets now able to leverage the platform include: ESL nurses in the United States: Nearly 20% of U.S. nurses have English as a Second Language (ESL) International healthcare systems treating U.S. patients: There are over 6.5 Million nurses in the top 10 medical tourist destinations for U.S. patients alone. Private clinics in multilingual regions: The private sector provides nearly 40% of all healthcare in PAHO, AFRO, and WPRO regions, 57% in SEARO, and 62% in EMRO. Madison Bush, Director of Corporate Operations, said, 'This rollout reflects our disciplined approach to targeting segments with clear, documented needs — including the nearly one in five nurses in the U.S. who speak English as a second language. By addressing the needs of this workforce, who must document in English, we're positioned to capture value domestically and expand internationally.' Sai Nittala, Senior AI Manager, said, 'NurseMagic™ V3.0 delivers healthcare charting solutions that outperform generic, off-the-shelf AI tools. Unlike many unregulated or non-integrated solutions, NurseMagic™ is designed for seamless integration into critical healthcare workflows — where compliance, accuracy, and efficiency are essential. Our multilingual capability underscores our ability to scale rapidly while meeting real-world needs.'' Dr. Ann Marie Sastry, Founder & CEO, said, 'We have growing B2B traction following our launch of enterprise administration tools, and are also supporting B2C growth in new segments that prepare us for global expansion. As reported in our Q3 2025 10‑Q, we achieved a 2.4× quarter-on-quarter revenue increase while continuing to cut operating expenses. We believe we're on track for further revenue growth and cost efficiencies in coming quarters.' NurseMagic™ is Now Available In: English, Chinese, Hindi, Spanish, French, Portuguese, Russian, Indonesian, German, Japanese, Korean, Turkish, Italian, Ukrainian, Dutch, Swedish. Amesite recently announced a 2.4x quarter-over-quarter revenue increase in its 10-Q filing, driven by rapid adoption of its NurseMagic™ platform and improvements in operating efficiency. The company also launched a higher-priced enterprise tier in response to growing B2B demand for more capacity. In April, Amesite reported that NurseMagic™ meets HIPAA requirements for individual users and enterprises, enabling secure documentation of protected health information across all user types. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions to improve care, enhance operational efficiency and improve financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ Sources
Yahoo
16-05-2025
- Business
- Yahoo
Amesite Announces Quarterly Revenue Increase of 2.4x in 10-Q Filing
Company Reports Accelerated Growth for both B2C and B2B, with Outstanding Customer Reviews into Q4 DETROIT, May 16, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a leading developer of AI-powered enterprise solutions, today announced its flagship app NurseMagicTM generated 2.4x revenue from Q2/2025 to Q3/2025, even as the company continued to cut operating expenses. Sarah Berman, Principal Financial and Accounting Officer, said, 'Our revenues are presently evenly distributed between B2B and B2C sales. Following the launch of NurseMagicTM in Q4/2024, revenues were stable from Q1/2025 to Q2/2025. However, in Q3/2025, we had a significant increase of 2.4x in revenue, following execution of targeted sales and marketing motions and rollouts of product enhancements. We also further reduced expenses while scaling sales this past quarter, retaining our strong focus on achieving further operational efficiencies and managing margins to drive to profitability.' Brandon Owens, VP of Sales, said, 'We delivered Teams Plus+ to our B2B customers in direct response to their need for greater intensity of usage, and expect accelerated business demands for more services, given the feedback. Our product testimonials are our best sales assets, and we are closing sales and onboarding teams within days or weeks, because of the efficiency of our payments and onboarding workflows." Madison Bush, Director of Corporate Operations, said, "We saw user growth of 1340% over Q3, following the launch of paid subscriptions in Q2. We have expanded our mobile marketing and are communicating with our users at every step of their journey to attract and retain them. We are thrilled to see that nurses who are searching for AI-tools are finding and using NurseMagicTM because it delivers incredible value.' Dr. Ann Marie Sastry, CEO and Founder, said, 'We are confident that we can continue to deliver NurseMagicTM at an affordable price point to both B2C and B2B customers, while maintaining healthy margins – and look forward to more growth in Q4. Our outstanding customer feedback validates a strong product-market fit. With our nimble development process, we feel that we are in very good position to grow revenue efficiently, while delivering tiered services that enable us to expand into new segments opportunistically.' Amesite is focused on delivering value in large, growing segments, including the 16,700 Skilled Nursing and Home Health Care Facilities in the U.S., employing 1.38 million workers, and 8,514 hospice organizations employing 407,692 workers. With a total of 5.2 million RNs and 630,000 LPNs in the U.S., and demand rising across Senior Living, Skilled Nursing, and Hospice, Amesite is positioned with solutions that meet real needs. Recent rollouts include delivering to the growing hospice segment, meeting HIPAA requirements for all users, and offering a new, higher-priced tier for B2B users. About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagicTM, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagicTM is used by over 100 professions to improve care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as "may," "will," "should," "would," "expect," "plan," "believe," "intend," "look forward," and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise. Investor Relations ir@ in retrieving data Sign in to access your portfolio Error in retrieving data Error in retrieving data Error in retrieving data Error in retrieving data
Associated Press
11-03-2025
- Business
- Associated Press
Amesite Announces Successful Soft Rollout of NurseMagic™ Caregiver Solution, Expanding Its Addressable Market for Enterprise by 50%
DETROIT, March 11, 2025 (GLOBE NEWSWIRE) -- Amesite Inc. (NASDAQ: AMST), a pioneering technology company specializing in the development and marketing of B2C and B2B AI-driven solutions, today announced the early adoption of its non-clinical caregiver tool in NurseMagic™. The Caregiver NurseMagic™ Solution directly supports non-clinical workers in their day-to-day jobs, reducing the need for intensive intervention by management, and improving documentation, communication and patient care. Amesite sales are focused on home health care and skilled nursing. Agencies and corporations in these segments employ both clinical and non-clinical staff. Broadly, there are almost 3 million home health care and skilled nursing staff in the U.S., of which over 1.5 million are non-clinical healthcare support workers. By expanding NurseMagic™ solutions to meet the needs of non-clinical workers, Amesite estimates that it has expanded its addressable market for enterprise sales alone by around 50%. Amesite reports that an increasing number of customers have adopted NurseMagic™ for their entire teams, which include non-clinical staff such as CNAs, chaplains, social workers and nurse aides. Over the last three months, Amesite reported that its contracts with hospice providers have grown by over 3,000%, and contract sizes have increased by nearly 1,000%. This comes on the heels of Amesite's recent rollout of its automated purchase process that enables contract expansion with a few clicks, substantially shortening its sales cycle as it outreaches the over 50,000 businesses in its target segments. Brandon Owens, VP of Sales at Amesite, stated, 'We are accelerating contract closures, increasing deal sizes, and expanding existing agreements with a growing suite of features. Organizations that deploy our platform across their entire workforce realize a disproportionate advantage—dramatically reducing audit risk and operational costs. By delivering the right NurseMagic™ solution to every employee, we empower agencies and corporations to seamlessly scale their contracts to cover 100% of their workforce with just a few clicks.' Kalie Wortinger, Senior Manager of Engineering, said, 'We built our infrastructure to be able to train our proprietary AI with extreme speed and accuracy, while meeting HIPAA requirements. We plan to roll out several new tools in the coming months to address market needs, informed by engagement with a rapidly growing cohort of customers and sales prospects.' Amesite CEO Dr. Ann Marie Sastry stated, 'We firmly believe that AI will ultimately support 100% of the U.S. workforce. Healthcare—rife with inefficiencies and unmet needs—is a prime market for Amesite's solutions, including NurseMagic™. With dozens of under- or unserved segments, we have an enormous opportunity to drive impact for our customers and generate revenue.' About Amesite Inc. Amesite (NASDAQ: AMST) is an AI-driven company with an immediate aim to transform the $330 billion home and healthcare segments. Its flagship product, NurseMagic™, streamlines documentation for nurses and caregivers, reducing the time required from 20 minutes to just 20 seconds. NurseMagic™ is used by over 100 professions, improved care, enhanced operational efficiency and improved financial performance. Built on proprietary AI trained on industry-specific data, NurseMagic meets HIPAA regulations while improving accuracy and efficiency. The platform serves B2B and B2C users across 50 states and 21 countries, offering seamless integration into healthcare workflows and translations to over 50 languages. Forward-Looking Statements This communication contains forward-looking statements (including within the meaning of Section 21E of the Securities Exchange Act of 1934, as amended, and Section 27A of the Securities Act of 1933, as amended) concerning the Company, the Company's planned online machine learning platform, the Company's business plans, any future commercialization of the Company's online learning solutions, potential customers, business objectives and other matters. Forward-looking statements generally include statements that are predictive in nature and depend upon or refer to future events or conditions, and include words such as 'may,' 'will,' 'should,' 'would,' 'expect,' 'plan,' 'believe,' 'intend,' 'look forward,' and other similar expressions among others. Statements that are not historical facts are forward-looking statements. Forward-looking statements are based on current beliefs and assumptions that are subject to risks and uncertainties and are not guarantees of future performance. Actual results could differ materially from those contained in any forward-looking statement. Risks facing the Company and its planned platform are set forth in the Company's filings with the SEC. Except as required by applicable law, the Company undertakes no obligation to revise or update any forward-looking statement, or to make any other forward-looking statements, whether as a result of new information, future events or otherwise.
Yahoo
02-03-2025
- Business
- Yahoo
Amesite Inc. (AMST) Accelerates NurseMagic Sales with 95% Faster Enterprise Onboarding
We recently compiled a list of the . In this article, we are going to take a look at where Amesite Inc. (NASDAQ:AMST) stands against the other AI stocks. Just as the AI industry was catching up with the launch of the DeepSeek AI R1 model in January, sources divulged that the Hangzhou-based company is planning to release the R2 model as early as possible. The company was previously aiming to launch the R2 model in May. DeepSeek expects the R2 model to exhibit better coding and reasoning capabilities in multiple languages. The R1 model, which was built cost-effectively using relatively less powerful GPUs, triggered a $1 trillion sell-off in US and European markets. The speculation around the R2 model could potentially drive further volatility in America's AI landscape as investors question the narrative that US-based AI companies require hundreds of billions of dollars to develop AI systems. "The launch of DeepSeek's R2 model could be a pivotal moment in the AI industry. DeepSeek's success at creating cost-effective AI models would likely spur companies worldwide to accelerate their own efforts ... breaking the stranglehold of the few dominant players in the field." We selected AI stocks by reviewing news articles, stock analysis, and press releases. We listed the stocks in ascending order of their hedge fund sentiment taken from Insider Monkey's database of over 1000 hedge funds. Why are we interested in the stocks that hedge funds pile into? The reason is simple: our research has shown that we can outperform the market by imitating the top stock picks of the best hedge funds. Our quarterly newsletter's strategy selects 14 small-cap and large-cap stocks every quarter and has returned 373.4% since May 2014, beating its benchmark by 218 percentage points (). A computer screen showcasing Artificial Intelligence and Machine Learning algorithms at work. Amesite Inc. (NASDAQ:AMST) uses proprietary AI in its NurseMagic tool to streamline documentation workflow, improve patient communication, and save time for nurses and caregivers. Their HIPAA-compliant B2C and B2B solutions are helping to enhance operational efficiency, uplift care quality, and boost overall financial performance in the home care, hospice, and healthcare segments. On February 25th, Amesite Inc. (NASDAQ:AMST) announced the success of its automated sales flow for its enterprise solution, NurseMagic for Teams. The company claims that the new purchase flow has reduced the time to close an enterprise sale by 95%, as enterprise clients can complete their NurseMagic subscription in minutes. The result is higher sales conversion and technology adoption alongside lower audit risks and negative reviews for clients, as they now have the capability to onboard teams immediately on the platform. 'Speed matters in enterprise sales, especially in healthcare, where time saved translates directly to better patient care. With our successful, automated sales flow, healthcare organizations are onboarding employees onto the NurseMagic™ app in record time, ensuring their teams can start experiencing efficiency gains immediately.' Overall AMST ranks 8th on our list of AI stocks that investors likely missed. While we acknowledge the potential of AMST as an investment, our conviction lies in the belief that AI stocks hold greater promise for delivering higher returns and doing so within a shorter time frame. If you are looking for an AI stock that is more promising than AMST but that trades at less than 5 times its earnings, check out our report about the cheapest AI stock. READ NEXT: and . Disclosure: None. This article is originally published at Insider Monkey.
